LENZ Therapeutics, Inc. LENZ
3.50 USD +0.49 (+16.28%)
At closeNov 6, 2026, 4:20 PM EST
3.50 0.00 0.00%
After hours · Nov 6, 4:20 PM ET
3.00 Day range 3.51
3.01 52-week range 31.94
- YTD
- -78.13%
- 1 year
- -84.76%
Held by funds
55 US ETFs and mutual funds hold LENZ · largest positions
Ownership
Held by insiders 2.73%
Held by institutions 99.85%
Float held by institutions 102.64%
Institutions 182
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 14.65% | 4,178,823 | 131.13M | Jun 29, 2025 |
| Alpha Wave Global, LP | 12.66% | 3,612,211 | 113.35M | Jun 29, 2025 |
| Paradigm Biocapital Advisors LP | 6.02% | 1,717,066 | 53.88M | Jun 29, 2025 |
| Blackrock Inc. | 5.02% | 1,432,461 | 44.95M | Jun 29, 2025 |
| Vanguard Group Inc | 4.53% | 1,290,994 | 40.51M | Jun 29, 2025 |
| Adage Capital Partners GP L.L.C. | 3.94% | 1,122,738 | 35.23M | Jun 29, 2025 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.85% | 811,477 | 25.46M | Jun 29, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 1.40% | 398,938 | 12.52M | Sep 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.90% | 257,096 | 8.07M | Jun 29, 2025 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.63% | 178,821 | 5.61M | Jul 30, 2025 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.49% | 141,032 | 4.43M | Sep 29, 2025 |
| iShares Trust-iShares Biotechnology ETF | 0.49% | 138,483 | 4.35M | Sep 29, 2025 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHEVALLARD DANIEL R | Chief Financial Officer | Purchase | May 13, 2024 | 3,188 |
| MCCOLLUM JAMES W | Director | Purchase | May 12, 2024 | 0 |
| ODRICH MARC | Officer | Stock Award(Grant) | Mar 20, 2024 | 99,599 |
| OLSSON SHAWN | Officer | Conversion of Exercise of derivative security | Apr 8, 2025 | 4,733 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Mar 20, 2024 | 0 |
| SCHIMMELPENNINK EVERT B. | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 6, 2025 | 49,200 |